2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
8
Cardiotoxicity
6
Lymphoma
3
Heart Failure
3
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Hepatocellular
2
Ventricular Dysfunction
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Multiple Myeloma
1
Motor Activity
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hypertension, Portal
1
Hepatocellular Carcinoma With Portal Vein Thrombosis
1
Esophageal and Gastric Varices
1
Cardiovascular Abnormalities
1
Cardiomyopathies
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
413
Methotrexate
250
Cytarabine
235
Vincristine
192
fludarabine phosphate
174
Dexamethasone
171
fludarabine
147
Etoposide
143
Peripheral Blood Stem Cell Transplantation
137
Filgrastim
132
Whole-Body Irradiation
118
Mycophenolic Acid
116
Busulfan
113
Doxorubicin
110
Mercaptopurine
108
Tacrolimus
107
Cyclosporine
95
Radiotherapy
93
Melphalan
93
pegaspargase
90
Rituximab
90
Prednisone
87
Asparaginase
87
Daunorubicin
86
Granulocyte Colony-Stimulating Factor
76
blinatumomab
74
Antilymphocyte Serum
71
Calcium Dobesilate
69
Clofarabine
58
Thiotepa
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Carvedilol
×
Clear all
NCT01110824
2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3
Completed
90 enrolled